Finance
Company announces new investment of $2.9 million in Nulens
Published in Medical Devices and Surgical Technology Week, May 22nd, 2005
Nulens is developing a fully accommodative Intra-Ocular Lens (IOL) and is currently conducting preclinical trials. The investment will be in two installments. Following completion of the aggregate investment, Elron will hold approximately 25% of Nulens, on a fully diluted basis.
Doron Birger, Elron's president and CEO, said: "The new investment in Nulens is consistent with our strategy of new investments in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
More Articles from Medical Devices and Surgical Technology Week
- Acute Myocardial Infarction
23Na MRI useful for monitoring infarct healing - Cardiac Devices
Induction ovens do not interfere with ICD function - Laser-Accelerated Proton Therapy
Compact particle selection/beam collimation system devised - Magnesium Deficiency
Novel assay enables assessment of intracellular magnesium levels - Therapeutic Ultrasound
US treatment affects osteoblast integrin expression and differentiation - ACE Inhibitors
ACE-inhibitory peptides were isolated from soybean protein hydrolysates - More from this issue of Medical Devices and Surgical Technology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
